{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:41:34Z","timestamp":1769283694571,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000669"],"award-info":[{"award-number":["82000669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111594","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T02:48:43Z","timestamp":1706669323000},"page":"111594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The protease inhibitor E64d might attenuate the development of experimental anti-glomerular basement membrane disease through regulating the activation of Th1 cells"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-5950","authenticated-orcid":false,"given":"Qiu-hua","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ya","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie-kun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2024.111594_b0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrneph.2011.89","article-title":"Advances in human antiglomerular basement membrane disease","volume":"7","author":"Cui","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"26","key":"10.1016\/j.intimp.2024.111594_b0010","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","article-title":"Identification of the goodpasture antigen as the alpha 3(IV) chain of collagen IV","volume":"263","author":"Saus","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2024.111594_b0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI115625","article-title":"Molecular cloning of the human goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen","volume":"89","author":"Turner","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.intimp.2024.111594_b0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000523713","article-title":"Predictors of kidney outcomes of anti-glomerular basement membrane disease in a large chinese cohort","volume":"53","author":"Jia","year":"2022","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111594_b0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2022.07.006","article-title":"Autoimmunity in anti-glomerular basement membrane disease: A review of mechanisms and prospects for immunotherapy","volume":"81","author":"Kuang","year":"2023","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.111594_b0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.126.6.989","article-title":"The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis","volume":"126","author":"Lerner","year":"1967","journal-title":"J. Exp. Med."},{"issue":"7653","key":"10.1016\/j.intimp.2024.111594_b0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22329","article-title":"Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2024.111594_b0040","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1046\/j.1523-1755.2003.00259.x","article-title":"Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in goodpasture's (anti-GBM) disease","volume":"64","author":"Salama","year":"2003","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.intimp.2024.111594_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030264","article-title":"Cysteine cathepsins and their extracellular roles: Shaping the microenvironment","volume":"8","author":"Vidak","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2024.111594_b0050","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.3389\/fimmu.2019.02037","article-title":"Cysteine cathepsins in tumor-associated immune cells","volume":"10","author":"Jakos","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.111594_b0055","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","article-title":"Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation","volume":"39","author":"Liszewski","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2024.111594_b0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2015.08.006","article-title":"The protease cathepsin L regulates Th17 cell differentiation","volume":"65","author":"Hou","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2024.111594_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107425","article-title":"Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis","volume":"93","author":"Shibamura-Fujiogi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111594_b0070","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192135","article-title":"Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation","volume":"218","author":"Reed","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.111594_b0075","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3389\/fimmu.2018.02449","article-title":"Asparaginyl endopeptidase (legumain) supports human Th1 induction via cathepsin L-mediated intracellular C3 activation","volume":"9","author":"Freeley","year":"2018","journal-title":"Front. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2024.111594_b0080","first-page":"400","article-title":"Role of cathepsin B and L in anti-glomerular basement membrane nephritis in rats","volume":"12","author":"Baricos","year":"1989","journal-title":"Ren. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.111594_b0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0003-9861(91)90222-5","article-title":"Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis","volume":"288","author":"Baricos","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.intimp.2024.111594_b0090","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1681\/ASN.2019060619","article-title":"Experimental antiglomerular basement membrane GN induced by a peptide from actinomyces","volume":"31","author":"Gu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111594_b0095","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/jcmm.13134","article-title":"The pathogenicity of T cell epitopes on human goodpasture antigen and its critical amino acid motif","volume":"21","author":"Hu","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.111594_b0100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1681\/ASN.2012070705","article-title":"The HLA-DRB1*15:01-restricted goodpasture's T cell epitope induces GN","volume":"24","author":"Ooi","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.intimp.2024.111594_b0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.kint.2016.06.035","article-title":"Cathepsin L is crucial for the development of early experimental diabetic nephropathy","volume":"90","author":"Garsen","year":"2016","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.intimp.2024.111594_b0110","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1172\/JCI25485","article-title":"Cathepsin L is essential for onset of autoimmune diabetes in NOD mice","volume":"115","author":"Maehr","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2024.111594_b0115","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1369\/0022155418791822","article-title":"Expression of cathepsin L and its intrinsic inhibitors in glomeruli of rats with puromycin aminonucleoside nephrosis","volume":"66","author":"Kubo","year":"2018","journal-title":"J. Histochem. Cytochem."},{"issue":"2","key":"10.1016\/j.intimp.2024.111594_b0120","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/path.5181","article-title":"Increased dynamin expression precedes proteinuria in glomerular disease","volume":"247","author":"Khalil","year":"2019","journal-title":"J. Pathol."},{"issue":"8","key":"10.1016\/j.intimp.2024.111594_b0125","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11255-017-1626-7","article-title":"Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans","volume":"49","author":"Cao","year":"2017","journal-title":"Int. Urol. Nephrol."},{"issue":"9","key":"10.1016\/j.intimp.2024.111594_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107648","article-title":"Urinary cathepsin L is predictive of changes in albuminuria and correlates with glucosepane in patients with type 2 diabetes in a closed-cohort study","volume":"34","author":"Brings","year":"2020","journal-title":"J. Diabetes Complications"},{"issue":"7","key":"10.1016\/j.intimp.2024.111594_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071611","article-title":"Identification of novel molecular markers of human Th17 cells","volume":"9","author":"Salkowska","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.111594_b0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.advenzreg.2003.11.004","article-title":"Critical role of cathepsin-inhibitors for autoantigen processing and autoimmunity","volume":"44","author":"Ishimaru","year":"2004","journal-title":"Adv. Enzyme Regul."},{"issue":"1","key":"10.1016\/j.intimp.2024.111594_b0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2249.2006.03188.x","article-title":"L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo","volume":"146","author":"Menzel","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"6 Pt 1","key":"10.1016\/j.intimp.2024.111594_b0150","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1562","article-title":"Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers","volume":"147","author":"Takahashi","year":"1993","journal-title":"Am. Rev. Respir. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:40:42Z","timestamp":1769229642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":30,"alternative-id":["S1567576924001127"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111594","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The protease inhibitor E64d might attenuate the development of experimental anti-glomerular basement membrane disease through regulating the activation of Th1 cells","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111594"}}